Ascendis Pharma A/S (ASND)
213.00
+7.17
(+3.48%)
USD |
NASDAQ |
Jan 20, 13:42
Ascendis Pharma EPS Diluted (Quarterly): -1.173 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.7044 |
| Evaxion AS | -0.2862 |
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -71.27M |
| Revenue (Quarterly) | 249.64M |
| Total Expenses (Quarterly) | 320.91M |
| Enterprise Value | 12.90B |
| Gross Profit Margin (Quarterly) | 87.87% |
| Profit Margin (Quarterly) | -28.55% |
| Earnings Yield | -1.99% |
| Normalized Earnings Yield | -1.994 |